SOLVENTUM CORP (SOLV) Stock Fundamental Analysis

NYSE:SOLV • US83444M1018

73.09 USD
-1.11 (-1.5%)
Last: Mar 2, 2026, 03:28 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 184 industry peers in the Health Care Equipment & Supplies industry. While SOLV belongs to the best of the industry regarding profitability, there are concerns on its financial health. SOLV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • In the past year SOLV had a positive cash flow from operations.
  • SOLV had positive earnings in each of the past 5 years.
  • In the past 5 years SOLV always reported a positive cash flow from operatings.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • SOLV has a Return On Assets of 10.89%. This is amongst the best in the industry. SOLV outperforms 94.02% of its industry peers.
  • SOLV's Return On Equity of 30.82% is amongst the best of the industry. SOLV outperforms 98.37% of its industry peers.
  • SOLV's Return On Invested Capital of 5.40% is fine compared to the rest of the industry. SOLV outperforms 76.63% of its industry peers.
  • SOLV had an Average Return On Invested Capital over the past 3 years of 8.39%. This is in line with the industry average of 8.97%.
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROIC 5.4%
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SOLV's Profit Margin of 18.69% is amongst the best of the industry. SOLV outperforms 94.02% of its industry peers.
  • SOLV's Profit Margin has improved in the last couple of years.
  • SOLV's Operating Margin of 8.53% is fine compared to the rest of the industry. SOLV outperforms 76.09% of its industry peers.
  • In the last couple of years the Operating Margin of SOLV has declined.
  • SOLV has a Gross Margin (53.57%) which is in line with its industry peers.
  • SOLV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SOLV is destroying value.
  • The number of shares outstanding for SOLV has been increased compared to 1 year ago.
  • SOLV has a better debt/assets ratio than last year.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.82. This is not the best score and indicates that SOLV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.82, SOLV perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
  • A Debt/Equity ratio of 1.00 indicates that SOLV is somewhat dependend on debt financing.
  • SOLV has a worse Debt to Equity ratio (1.00) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.54
WACC10.07%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • SOLV has a Current Ratio of 1.23. This is a normal value and indicates that SOLV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SOLV (1.23) is worse than 81.52% of its industry peers.
  • A Quick Ratio of 0.89 indicates that SOLV may have some problems paying its short term obligations.
  • SOLV has a worse Quick ratio (0.89) than 81.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.89
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • SOLV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.82%.
  • Measured over the past 5 years, SOLV shows a small growth in Earnings Per Share. The EPS has been growing by 4.46% on average per year.
  • SOLV shows a small growth in Revenue. In the last year, the Revenue has grown by 0.86%.
  • Measured over the past years, SOLV shows a small growth in Revenue. The Revenue has been growing by 0.79% on average per year.
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%

3.2 Future

  • SOLV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.21% yearly.
  • SOLV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.78% yearly.
EPS Next Y6.14%
EPS Next 2Y7.42%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue Next Year-3.21%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.29%
Revenue Next 5Y0.78%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.98 indicates a reasonable valuation of SOLV.
  • Based on the Price/Earnings ratio, SOLV is valued cheaper than 93.48% of the companies in the same industry.
  • SOLV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.07.
  • Based on the Price/Forward Earnings ratio of 11.29, the valuation of SOLV can be described as reasonable.
  • SOLV's Price/Forward Earnings ratio is rather cheap when compared to the industry. SOLV is cheaper than 93.48% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. SOLV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.98
Fwd PE 11.29
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 84.24% of the companies in the same industry are more expensive than SOLV, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.2
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SOLV does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y7.42%
EPS Next 3Y9.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SOLV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLVENTUM CORP

NYSE:SOLV (3/2/2026, 3:28:02 PM)

73.09

-1.11 (-1.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners72.36%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner Change0.17%
Market Cap12.68B
Revenue(TTM)8.32B
Net Income(TTM)1.56B
Analysts75.24
Price Target91.16 (24.72%)
Short Float %2.48%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.79%
Min EPS beat(2)2.66%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)8
Avg EPS beat(8)8.33%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.1%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.18%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.82%
PT rev (3m)5.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.12%
EPS NY rev (1m)0%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 11.98
Fwd PE 11.29
P/S 1.52
P/FCF N/A
P/OCF 34.36
P/B 2.51
P/tB N/A
EV/EBITDA 14.2
EPS(TTM)6.1
EY8.35%
EPS(NY)6.47
Fwd EY8.86%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.13
OCFY2.91%
SpS48
BVpS29.11
TBVpS-18.72
PEG (NY)1.95
PEG (5Y)N/A
Graham Number63.21
Profitability
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROCE 6.36%
ROIC 5.4%
ROICexc 5.87%
ROICexgc 30.39%
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
FCFM N/A
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
ROICexc(3y)8.79%
ROICexc(5y)10.16%
ROICexgc(3y)43.79%
ROICexgc(5y)51.79%
ROCE(3y)9.88%
ROCE(5y)11.65%
ROICexgc growth 3Y-18.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.41%
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 77.51%
Cap/Sales 4.55%
Interest Coverage 1.61
Cash Conversion 30.78%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.89
Altman-Z 1.82
F-Score6
WACC10.07%
ROIC/WACC0.54
Cap/Depr(3y)65.89%
Cap/Depr(5y)57.5%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y6.14%
EPS Next 2Y7.42%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-3.21%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.29%
Revenue Next 5Y0.78%
EBIT growth 1Y-31.93%
EBIT growth 3Y-24.87%
EBIT growth 5YN/A
EBIT Next Year21.16%
EBIT Next 3Y5.93%
EBIT Next 5YN/A
FCF growth 1Y-101.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.86%
OCF growth 3Y-39.65%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVENTUM CORP?

SOLVENTUM CORP (SOLV) has a profitability rating of 7 / 10.


How financially healthy is SOLVENTUM CORP?

The financial health rating of SOLVENTUM CORP (SOLV) is 2 / 10.